CN Stock MarketDetailed Quotes

Shaanxi Panlong Pharmaceutical (002864)

Watchlist
  • 31.81
  • -0.61-1.88%
Market Closed Apr 17 15:00 CST
3.38BMarket Cap28.05P/E (TTM)

Shaanxi Panlong Pharmaceutical (002864) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
Total operating revenue
17.37%841.45M
26.06%574.02M
19.08%250.21M
-0.71%973.86M
0.10%716.92M
-8.93%455.36M
-6.87%210.12M
0.67%980.83M
3.29%716.23M
16.02%500.02M
Operating revenue
17.37%841.45M
26.06%574.02M
19.08%250.21M
-0.71%973.86M
0.10%716.92M
-8.93%455.36M
-6.87%210.12M
0.67%980.83M
3.29%716.23M
16.02%500.02M
Other operating revenue
----
22.63%1.25M
----
-8.11%2.41M
----
-21.09%1.02M
----
-19.32%2.63M
----
-3.20%1.29M
Total operating cost
18.29%735.24M
28.13%502.13M
19.26%213.74M
-0.37%843.76M
0.32%621.57M
-10.09%391.91M
-10.46%179.23M
-0.31%846.85M
3.69%619.61M
16.12%435.9M
Operating cost
45.27%398.13M
64.17%280.8M
44.23%115.32M
-7.57%381.52M
-8.44%274.06M
-24.28%171.04M
-30.01%79.96M
1.16%412.75M
3.12%299.31M
19.76%225.89M
Operating tax surcharges
4.34%8.72M
4.39%5.81M
12.71%2.81M
2.50%11.17M
13.32%8.35M
15.08%5.57M
27.89%2.49M
6.46%10.9M
2.74%7.37M
7.33%4.84M
Operating expense
-4.93%271.15M
-0.60%181.09M
-3.83%84.21M
1.64%367.02M
6.80%285.23M
4.10%182.18M
21.24%87.56M
-0.45%361.1M
3.94%267.07M
11.38%175M
Administration expense
-4.54%45.83M
-2.73%30.44M
5.63%13.41M
21.04%69.83M
16.83%48.01M
17.74%31.29M
4.09%12.69M
8.10%57.69M
14.56%41.1M
22.24%26.58M
Financial expense
29.22%-12.69M
4.62%-11.86M
7.54%-6.66M
-47.29%-23.32M
-63.29%-17.93M
-76.91%-12.43M
-93.41%-7.2M
-406.45%-15.83M
-498.71%-10.98M
-868.12%-7.03M
-Interest expense (Financial expense)
-9.48%2.39M
-11.22%1.52M
-9.76%723.79K
-74.45%1.56M
-48.26%2.64M
-54.95%1.71M
-63.24%802.1K
-56.08%6.11M
-51.16%5.1M
-45.32%3.8M
-Interest Income (Financial expense)
26.62%-15.13M
5.44%-13.42M
7.70%-7.39M
-13.06%-24.95M
-27.34%-20.62M
-30.05%-14.19M
-34.84%-8.01M
-28.41%-22.06M
-30.88%-16.19M
-41.03%-10.91M
Research and development
1.05%24.1M
11.18%15.85M
24.87%4.64M
85.31%37.54M
51.49%23.85M
34.24%14.26M
13.33%3.72M
11.09%20.26M
71.89%15.74M
157.75%10.62M
Credit Impairment Loss
-89.85%-7.35M
-71.81%-9.17M
-13.27%-2.36M
43.07%-2.22M
0.95%-3.87M
-32.56%-5.34M
-14.81%-2.08M
12.84%-3.9M
-173.48%-3.91M
-570.86%-4.03M
Asset Impairment Loss
-2,882.19%-211.24K
6.29%-187.61K
120.91%55.06K
77.32%-225K
99.16%-7.08K
42.14%-200.2K
-307.67%-263.29K
-311.35%-992.18K
-11,381.29%-839.85K
-1,090.35%-346K
Other net revenue
-35.75%1.73M
-96.75%-1.23M
-10.13%-248.44K
832.22%8.26M
96.44%2.69M
41.53%-623.08K
45.67%-225.58K
149.10%886.17K
4.76%1.37M
-165.55%-1.07M
Invest income
-1.52%-174.19K
-1.88%-119.5K
-2.56%-53.13K
140.53%630.89K
85.30%-171.59K
-11.50%-117.29K
-1,755.90%-51.81K
-1,282.11%-1.56M
-890.51%-1.17M
---105.2K
-Including: Investment income associates
-1.52%-174.19K
-1.88%-119.5K
-2.56%-53.13K
382.51%499.2K
-10.59%-171.59K
-11.50%-117.29K
-1,755.90%-51.81K
-56.90%-176.7K
-31.70%-155.16K
---105.2K
Asset deal income
3,000.66%129.68K
-8,100.60%-10.51K
---315.97
-108.40%-14.13K
59.47%-4.47K
98.84%-128.18
----
--168.16K
---11.03K
---11.03K
Other revenue
38.44%9.33M
64.19%8.26M
-2.90%2.11M
40.77%10.09M
-7.59%6.74M
46.99%5.03M
47.61%2.17M
137.00%7.17M
155.09%7.29M
51.85%3.42M
Operating profit
10.10%107.94M
12.47%70.66M
18.14%36.23M
2.60%138.37M
0.05%98.04M
-0.36%62.83M
22.45%30.66M
9.62%134.86M
0.84%97.99M
10.19%63.06M
Add:Non operating Income
-98.57%73.45K
-98.93%54.6K
-99.97%1.31K
-56.16%193.54K
1,281.53%5.14M
1,995.27%5.11M
1,964.27%5.04M
-3.22%441.48K
117.60%371.93K
1,294.75%243.91K
Less:Non operating expense
-18.45%1.3M
142.77%656.22K
-88.48%7.4K
-73.42%1.61M
123.36%1.6M
167.76%270.31K
-44.89%64.22K
40.80%6.05M
-82.75%715.65K
-97.51%100.95K
Total profit
5.05%106.71M
3.54%70.06M
1.63%36.22M
5.96%136.95M
4.03%101.58M
7.07%67.67M
41.60%35.64M
8.45%129.25M
4.78%97.64M
18.84%63.2M
Less:Income tax cost
39.15%17.11M
22.46%10.08M
10.36%5.05M
-3.82%17.03M
-6.35%12.29M
-1.14%8.23M
36.47%4.58M
10.42%17.7M
-0.92%13.13M
10.18%8.33M
Net profit
0.36%89.6M
0.92%59.98M
0.35%31.17M
7.51%119.92M
5.64%89.28M
8.32%59.44M
42.39%31.06M
8.14%111.55M
5.72%84.52M
20.27%54.87M
Net profit from continuing operation
0.36%89.6M
0.92%59.98M
0.35%31.17M
7.51%119.92M
5.64%89.28M
8.32%59.44M
42.39%31.06M
8.14%111.55M
5.72%84.52M
20.27%54.87M
Less:Minority Profit
29.61%-203.45K
28.53%-155.68K
6.58%-83.43K
-131.17%-346.9K
-170.25%-289.04K
-135.34%-217.82K
-135.63%-89.31K
-43.89%1.11M
-79.14%411.43K
-18.06%616.37K
Net profit of parent company owners
0.26%89.81M
0.81%60.14M
0.33%31.25M
8.91%120.27M
6.50%89.57M
9.95%59.65M
44.46%31.15M
9.16%110.43M
7.87%84.1M
20.92%54.25M
Earning per share
Basic earning per share
0.00%0.85
0.00%0.57
0.00%0.3
0.00%1.15
-6.59%0.85
-1.72%0.57
25.00%0.3
-2.54%1.15
0.00%0.91
11.54%0.58
Diluted earning per share
0.00%0.85
0.00%0.57
0.00%0.3
1.77%1.15
-6.59%0.85
-1.72%0.57
30.43%0.3
-3.42%1.13
3.27%0.91
16.00%0.58
Other composite income
Total composite income
0.36%89.6M
0.92%59.98M
0.35%31.17M
7.51%119.92M
5.64%89.28M
8.32%59.44M
42.39%31.06M
8.14%111.55M
5.72%84.52M
20.27%54.87M
Total composite income of parent company owners
0.26%89.81M
0.81%60.14M
0.33%31.25M
8.91%120.27M
6.50%89.57M
9.95%59.65M
44.46%31.15M
9.16%110.43M
7.87%84.1M
20.92%54.25M
Total composite income of minority owners
29.61%-203.45K
28.53%-155.68K
6.58%-83.43K
-131.17%-346.9K
-170.25%-289.04K
-135.34%-217.82K
-135.63%-89.31K
-43.89%1.11M
-79.14%411.43K
-18.06%616.37K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023
Total operating revenue 17.37%841.45M26.06%574.02M19.08%250.21M-0.71%973.86M0.10%716.92M-8.93%455.36M-6.87%210.12M0.67%980.83M3.29%716.23M16.02%500.02M
Operating revenue 17.37%841.45M26.06%574.02M19.08%250.21M-0.71%973.86M0.10%716.92M-8.93%455.36M-6.87%210.12M0.67%980.83M3.29%716.23M16.02%500.02M
Other operating revenue ----22.63%1.25M-----8.11%2.41M-----21.09%1.02M-----19.32%2.63M-----3.20%1.29M
Total operating cost 18.29%735.24M28.13%502.13M19.26%213.74M-0.37%843.76M0.32%621.57M-10.09%391.91M-10.46%179.23M-0.31%846.85M3.69%619.61M16.12%435.9M
Operating cost 45.27%398.13M64.17%280.8M44.23%115.32M-7.57%381.52M-8.44%274.06M-24.28%171.04M-30.01%79.96M1.16%412.75M3.12%299.31M19.76%225.89M
Operating tax surcharges 4.34%8.72M4.39%5.81M12.71%2.81M2.50%11.17M13.32%8.35M15.08%5.57M27.89%2.49M6.46%10.9M2.74%7.37M7.33%4.84M
Operating expense -4.93%271.15M-0.60%181.09M-3.83%84.21M1.64%367.02M6.80%285.23M4.10%182.18M21.24%87.56M-0.45%361.1M3.94%267.07M11.38%175M
Administration expense -4.54%45.83M-2.73%30.44M5.63%13.41M21.04%69.83M16.83%48.01M17.74%31.29M4.09%12.69M8.10%57.69M14.56%41.1M22.24%26.58M
Financial expense 29.22%-12.69M4.62%-11.86M7.54%-6.66M-47.29%-23.32M-63.29%-17.93M-76.91%-12.43M-93.41%-7.2M-406.45%-15.83M-498.71%-10.98M-868.12%-7.03M
-Interest expense (Financial expense) -9.48%2.39M-11.22%1.52M-9.76%723.79K-74.45%1.56M-48.26%2.64M-54.95%1.71M-63.24%802.1K-56.08%6.11M-51.16%5.1M-45.32%3.8M
-Interest Income (Financial expense) 26.62%-15.13M5.44%-13.42M7.70%-7.39M-13.06%-24.95M-27.34%-20.62M-30.05%-14.19M-34.84%-8.01M-28.41%-22.06M-30.88%-16.19M-41.03%-10.91M
Research and development 1.05%24.1M11.18%15.85M24.87%4.64M85.31%37.54M51.49%23.85M34.24%14.26M13.33%3.72M11.09%20.26M71.89%15.74M157.75%10.62M
Credit Impairment Loss -89.85%-7.35M-71.81%-9.17M-13.27%-2.36M43.07%-2.22M0.95%-3.87M-32.56%-5.34M-14.81%-2.08M12.84%-3.9M-173.48%-3.91M-570.86%-4.03M
Asset Impairment Loss -2,882.19%-211.24K6.29%-187.61K120.91%55.06K77.32%-225K99.16%-7.08K42.14%-200.2K-307.67%-263.29K-311.35%-992.18K-11,381.29%-839.85K-1,090.35%-346K
Other net revenue -35.75%1.73M-96.75%-1.23M-10.13%-248.44K832.22%8.26M96.44%2.69M41.53%-623.08K45.67%-225.58K149.10%886.17K4.76%1.37M-165.55%-1.07M
Invest income -1.52%-174.19K-1.88%-119.5K-2.56%-53.13K140.53%630.89K85.30%-171.59K-11.50%-117.29K-1,755.90%-51.81K-1,282.11%-1.56M-890.51%-1.17M---105.2K
-Including: Investment income associates -1.52%-174.19K-1.88%-119.5K-2.56%-53.13K382.51%499.2K-10.59%-171.59K-11.50%-117.29K-1,755.90%-51.81K-56.90%-176.7K-31.70%-155.16K---105.2K
Asset deal income 3,000.66%129.68K-8,100.60%-10.51K---315.97-108.40%-14.13K59.47%-4.47K98.84%-128.18------168.16K---11.03K---11.03K
Other revenue 38.44%9.33M64.19%8.26M-2.90%2.11M40.77%10.09M-7.59%6.74M46.99%5.03M47.61%2.17M137.00%7.17M155.09%7.29M51.85%3.42M
Operating profit 10.10%107.94M12.47%70.66M18.14%36.23M2.60%138.37M0.05%98.04M-0.36%62.83M22.45%30.66M9.62%134.86M0.84%97.99M10.19%63.06M
Add:Non operating Income -98.57%73.45K-98.93%54.6K-99.97%1.31K-56.16%193.54K1,281.53%5.14M1,995.27%5.11M1,964.27%5.04M-3.22%441.48K117.60%371.93K1,294.75%243.91K
Less:Non operating expense -18.45%1.3M142.77%656.22K-88.48%7.4K-73.42%1.61M123.36%1.6M167.76%270.31K-44.89%64.22K40.80%6.05M-82.75%715.65K-97.51%100.95K
Total profit 5.05%106.71M3.54%70.06M1.63%36.22M5.96%136.95M4.03%101.58M7.07%67.67M41.60%35.64M8.45%129.25M4.78%97.64M18.84%63.2M
Less:Income tax cost 39.15%17.11M22.46%10.08M10.36%5.05M-3.82%17.03M-6.35%12.29M-1.14%8.23M36.47%4.58M10.42%17.7M-0.92%13.13M10.18%8.33M
Net profit 0.36%89.6M0.92%59.98M0.35%31.17M7.51%119.92M5.64%89.28M8.32%59.44M42.39%31.06M8.14%111.55M5.72%84.52M20.27%54.87M
Net profit from continuing operation 0.36%89.6M0.92%59.98M0.35%31.17M7.51%119.92M5.64%89.28M8.32%59.44M42.39%31.06M8.14%111.55M5.72%84.52M20.27%54.87M
Less:Minority Profit 29.61%-203.45K28.53%-155.68K6.58%-83.43K-131.17%-346.9K-170.25%-289.04K-135.34%-217.82K-135.63%-89.31K-43.89%1.11M-79.14%411.43K-18.06%616.37K
Net profit of parent company owners 0.26%89.81M0.81%60.14M0.33%31.25M8.91%120.27M6.50%89.57M9.95%59.65M44.46%31.15M9.16%110.43M7.87%84.1M20.92%54.25M
Earning per share
Basic earning per share 0.00%0.850.00%0.570.00%0.30.00%1.15-6.59%0.85-1.72%0.5725.00%0.3-2.54%1.150.00%0.9111.54%0.58
Diluted earning per share 0.00%0.850.00%0.570.00%0.31.77%1.15-6.59%0.85-1.72%0.5730.43%0.3-3.42%1.133.27%0.9116.00%0.58
Other composite income
Total composite income 0.36%89.6M0.92%59.98M0.35%31.17M7.51%119.92M5.64%89.28M8.32%59.44M42.39%31.06M8.14%111.55M5.72%84.52M20.27%54.87M
Total composite income of parent company owners 0.26%89.81M0.81%60.14M0.33%31.25M8.91%120.27M6.50%89.57M9.95%59.65M44.46%31.15M9.16%110.43M7.87%84.1M20.92%54.25M
Total composite income of minority owners 29.61%-203.45K28.53%-155.68K6.58%-83.43K-131.17%-346.9K-170.25%-289.04K-135.34%-217.82K-135.63%-89.31K-43.89%1.11M-79.14%411.43K-18.06%616.37K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and Show More